The 12-Month Price Target For Myriad Genetics, Inc (NASDAQ:MYGN) Is Now 18.
In last trading session, Myriad Genetics, Inc (NASDAQ:MYGN) saw 1.05 million shares changing hands with its beta currently measuring 1.88. Company’s recent per share price
In last trading session, Myriad Genetics, Inc (NASDAQ:MYGN) saw 1.05 million shares changing hands with its beta currently measuring 1.88. Company’s recent per share price
In the last trading session, 2.16 million Myriad Genetics, Inc (NASDAQ:MYGN) shares changed hands as the company’s beta touched 1.86. With the company’s per share
Myriad Genetics, Inc (NASDAQ:MYGN) has a beta value of 1.85 and has seen 4.13 million shares traded in the last trading session. The company, currently
During the last session, Myriad Genetics, Inc (NASDAQ:MYGN)’s traded shares were 1.66 million, with the beta value of the company hitting 1.87. At the end
In the last trading session, 1.61 million shares of the Myriad Genetics, Inc (NASDAQ:MYGN) were traded, and its beta was 1.89. Most recently the company’s
In the last trading session, 1.82 million Myriad Genetics, Inc (NASDAQ:MYGN) shares changed hands as the company’s beta touched 1.81. With the company’s per share
© 2024, Powered by Smart TechOne